Gene · 84433
CARD11: caspase recruitment domain family member 11
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CARD11: caspase recruitment domain family member 11. Genes, record 84433. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/84433
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BXL7 | Caspase recruitment domain-containing protein 11 | 1,154 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents32
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40227 | Q9BXL7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 11967 | Q9BXL7 | Espacenet |
| JP 2025532979 A | 2025-10-03 | 26 | Q9BXL7 | Espacenet |
| EP 4593850 A2 | 2025-08-06 | 26 | Q9BXL7 | Espacenet |
| JP 2025524002 A | 2025-07-25 | 8 | Q9BXL7 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 11967 | Q9BXL7 | Espacenet |
| US 12295971 B2 | 2025-05-13 | 26 | Q9BXL7 | Espacenet |
| KR 1020250039465 A | 2025-03-20 | 8 | Q9BXL7 | Espacenet |
| WO 2025049972 A1 | 2025-03-06 | 1326 | Q9BXL7 | Espacenet |
| JP 2024028924 A | 2024-03-05 | 4 | Q9BXL7 | Espacenet |
1 to 10 of 32
See all 32 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,439
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CARD11 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 34 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 32 | 2025 |
| ZIABC011008 | Oncogenic mechanisms and molecular targets in lymphoma | 18 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 13 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 11 | 2025 |
| ZIABC011007 | Functional genomic screens for molecular targets in cancer | 9 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 8 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 7 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 7 | 2025 |
| ZIABC011070 | Hematopathology Diagnosis | 7 | 2025 |
1 to 10 of 1,439Source NIH's project files
See all 1,439 nih grantsPapers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Running on Empty Signals: What Human MALT1 Deficiency Reveals About Immune Control. | J Immunol Res | 2026 | 42745540 | PubTator, text mining | PubMed |
| Genetic Heterogeneity of Inborn Errors of Immunity Revealed by Whole-Genome Sequencing: Insights from a Russian Patient Cohort. | Int J Mol Sci | 2026 | 42737820 | PubTator, text mining | PubMed |
| Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models. | Blood Neoplasia | 2026 | 42571242 | PubTator, text mining | PubMed |
| [Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544655 | PubTator, text mining | PubMed |
| The requirement of MALT1 activity for the growth of adult T cell leukemia/lymphoma. | iScience | 2026 | 42542590 | PubTator, text mining | PubMed |
| Genomic landscape of rare variants in a Chinese autism cohort and discovery of novel risk genes. | Mol Psychiatry | 2026 | 42463903 | PubTator, text mining | PubMed |
| A Network Toxicology Framework for Identification of Immune System Disruption by Per- and Polyfluoroalkyl Substance (PFAS) Mixture: In Silico Analysis. | J Xenobiot | 2026 | 42346437 | PubTator, text mining | PubMed |
| Cold Agglutinin Disease-Like Genetic Signatures in Lymphoplasmacytic Lymphoma-Like Cases Challenge the WHO Fifth Edition Classification. | EJHaem | 2026 | 42317281 | PubTator, text mining | PubMed |
| Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function. | Clin Exp Immunol | 2026 | 42284456 | PubTator, text mining | PubMed |
| Identification of BRCA2 Likely Germline Pathogenic Variants in Patients with Multiple Primary Lung Adenocarcinomas. | Oncol Res | 2026 | 42232598 | PubTator, text mining | PubMed |
1 to 10 of 2,534
See all 2,534 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/84433
GET https://conductscience.org/api/genes/v1/84433/patents?page=2